Bal Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹90 crore and net profit of ₹1.43 crore for the September 2026 quarter.
Bal Pharma (NSE: BALPHARMA-BE) closed at ₹83.21 on 20 Nov 2026. Its market capitalisation is ₹132 crore and it trades at 16.7 times earnings.
Incorporated in 1987, Bal Pharma Ltd does manufacturing and selling of pharmaceutical products and related services
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.